Vasopressor use for severe hypotension-a multicentre prospective observational study

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Lamontagne, Francois ^a,b   Cook, Deborah J ^c   Meade, Maureen O ^c   Seely, Andrew ^d,e   Day, Andrew G ^f   Charbonney, Emmanuel ^g,h   Serri, Karim ^g   Skrobik, Yoanna ⁱ   Hebert, Paul ⁱ   St Arnaud, Charles ^a   Quiroz Martinez, Hector ^a   Mayette, Michael ^a   Heyland, Daren K ^f  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f KINGSTON GENERAL HOSPITAL   (Canada)

^g HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^h MCGILL UNIVERSITY   (Canada)

ⁱ CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; VASOCONSTRICTOR AGENT;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE REGULATION; CANADIAN; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG USE; FEMALE; HOSPITAL MORTALITY; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TREATMENT DURATION; CANADA; CLINICAL TRIAL; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CANADA; FEMALE; HUMANS; HYPERTENSION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASOCONSTRICTOR AGENTS;

EID: 85010289374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167840     Document Type: Article

References (15)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. The New England journal of medicine. 2013; 369(21):2063.
2. Vincent JL, De Backer D. Circulatory shock. The New England journal of medicine. 2013; 369 (18):1726-34. doi: 10.1056/NEJMra1208943 PMID: 24171518
3. Hollenberg SM. Vasopressor support in septic shock. Chest. 2007; 132(5):1678-87. doi: 10.1378/chest.07-0291 PMID: 17998371
4. Hollenberg SM. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med. 2011; 183(7):847-55. Epub2010/11/26. 201006-0972CI [pii]. doi: 10.1164/rccm.201006-0972CI PMID: 21097695
5. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Critical care medicine. 2004; 32 (9):1928-48. PMID: 15343024
6. Dunser MW, Mayr AJ, Tur A, Pajk W, Barbara F, Knotzer H, et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Critical care medicine. 2003; 31(5):1394-8. Epub 2003/05/29. doi: 10.1097/01.CCM. 0000059722.94182.79 PMID: 12771608
7. Schmittinger CA, Torgersen C, Luckner G, Schroder DC, Lorenz I, Dunser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med. 2012; 38(6):950-8. Epub 2012/04/25. doi: 10.1007/s00134-012-2531-2 PMID: 22527060
8. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical care medicine. 2013; 41(2):580-637. Epub 2013/01/29. doi: 10.1097/CCM.0b013e31827e83af PMID: 23353941
9. Lamontagne F, Cook DJ, Adhikari NK, Briel M, Duffett M, Kho ME, et al. Vasopressor administration and sepsis: a survey of Canadian intensivists. J Crit Care. 2011; 26(5):532 e1-7. Epub 2011/04/02. S0883-9441(11)00037-2 [pii].
10. St-Arnaud C, Ethier J, Leclair M, Lamontagne F. Prescribed targets for vasopressor titration in septic shock: a retrospective cohort study. Intensive Care Med. 2011; 37(Suppl. 1):231.
11. Brown SM, Lanspa MJ, Jones JP, Kuttler KG, Li Y, Carlson R, et al. Survival after shock requiring high-dose vasopressor therapy. Chest. 2013; 143(3):664-71. Epub 2012/08/23. PubMed Central PMCID: PMC3590882. doi: 10.1378/chest.12-1106 PMID: 22911566
12. Shah B, Sucher K, Hollenbeck CB. Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States. Nutr Clin Pract. 2006; 21(3):312-9. PMID: 16772549
13. Heyland DK, Muscedere J, Drover J, Jiang X, Day AG. Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials. Crit Care. 2011; 15(2):R98. Epub 2011/03/23. PubMed Central PMCID: PMC3219367. doi: 10.1186/cc10110 PMID: 21418560
14. Koczmara CK, St-Arnaud C, Martinez HQ, Adhikari NK, Meade M, Berard D, et al. Vasopressor stewardship: a case report and lesson shared. Dynamics. 2014; 25(1):26-9. PMID: 24716392
15. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus Low Blood-Pressure Target in Patients with Septic Shock. The New England journal of medicine. 2014. Epub 2014/03/19.